Osteoporosis Drugs
May 7, 2024 by Vivian Goldschmidt, MA
Discover What Is Polypharmacy And If It Is A Threat To Your Bones And Wellbeing
As Big Pharma has risen to power and gained outsized influence within the Medical Establishment a troubling trend has emerged: polypharmacy. Polypharmacy is a situation in which a person is … Continue Reading →
March 12, 2024 by Vivian Goldschmidt, MA
Save Our Bones Bulletin: New Bone-Resorption Regulator Discovered; How Aerobic Exercise Impacts Non-Alcoholic Fatty Liver Disease; Medical Device For Reducing Bone Loss Approved
In this month’s bulletin, you’ll get the latest updates in the field of bone health. First, you’ll get the most recent news on research revealing how newly discovered proteins help … Continue Reading →
February 26, 2024 by Vivian Goldschmidt, MA
Alert! The FDA Issued Its Strictest Warning For Deadly Effects Of Osteoporosis Drug Prolia
The Food and Drug Administration (FDA) has added its strictest warning to Amgen’s osteoporosis drug Prolia (denosumab). The move comes after years of additional monitoring and testing of a known … Continue Reading →
November 20, 2023 by Vivian Goldschmidt, MA
Save Our Bones Bulletin: Skeletal Stem Cells Control Effects of Aging; Pain Reprocessing Therapy Offers Alternative To Painkillers; New Dangers Of Aspartame Uncovered
This month’s Save Our Bones Bulletin brings you breaking news from the realms of stem cell research, mental approaches to physical pain, and a shocking revelation regarding a widely used … Continue Reading →
September 4, 2023 by Vivian Goldschmidt, MA
How Osteoporosis Drugs Cause Disruptions Of Vital Communication Between Bone Cells
Our bones are maintained through a continuous cycle of remodeling. Specialized cells called osteoblasts and osteoclasts are responsible for creating new bone and resorbing old bone, respectively. A scientific study … Continue Reading →
August 22, 2023 by Vivian Goldschmidt, MA
Alert! Scientists Repeat Old Mistakes Attempting To Create A New Osteoporosis Drug
A recent study has unveiled a new osteoporosis drug under development. However, the direction the researchers are taking closely resembles an existing osteoporosis drug: Evenity (romosozumab). The researchers promote their … Continue Reading →
August 14, 2023 by Vivian Goldschmidt, MA
Save Our Bones Bulletin: New Compound Could Become Next Osteoporosis Drug; A Robotic Pill That Delivers Injectable Drugs; Hip Fracture Rates Decline, But Total Hip Fractures To Increase
This month’s bulletin starts off with a warning. Medical researchers have announced the development of yet another osteoporosis drug. We’ll look at the details and what to expect. Then we’ll … Continue Reading →
August 9, 2023 by Vivian Goldschmidt, MA
Which Is More Effective: Diet Or Drugs?
Today we’ll be tackling one of the most confounding and troubling trends in modern medicine. Scientific studies have confirmed again and again that for many ailments and conditions, dietary changes … Continue Reading →
June 26, 2023 by Vivian Goldschmidt, MA
Alert: Deadly Side Effect Of Osteoporosis Drug Exposed
A study led by the University of Bristol in the UK has found that the mechanism of action of the osteoporosis drug romosozumab (Evenity) increases the risk of heart attack … Continue Reading →
May 8, 2023 by Vivian Goldschmidt, MA
Save Our Bones Bulletin: New Bisphosphonate Risk Calculator; Study Compares Fracture Prediction Tools; Tryptophan And Bone-Muscle Communication
This month we take a deep dive into a range of research relating to bone health and the future of osteoporosis interventions. First, we’ll look at a new initiative to … Continue Reading →